
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 162
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT05863325 | A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC) | ||
NCT04218734 | A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM | ||
NCT05445154 | SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) | ||
NCT04225195 | Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis | ||
NCT03456388 | Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects | ||
NCT04364997 | Study of Desvenlafaxine in Treating Major Depressive Disorder. | ||
NCT03922373 | A Study of Benzonatate Soft Capsule in Chinese Healthy Subjects | ||
NCT04448379 | Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer | ||
NCT03577509 | Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China | ||
NCT04036656 | Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers | ||
NCT02059785 | Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke | ||
NCT05901935 | DP303c in Patients With HER2-positive Advanced Breast Cancer | ||
NCT07165886 | Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors | ||
NCT05108545 | A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and Fever | ||
NCT05072028 | Mass Balance and Biotransformation Study of [14C]DBPR108 in Human | ||
NCT03553914 | PLM60 for Peripheral T Cell Lymphoma (PTCL) | ||
NCT05345938 | A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia | ||
NCT04404543 | A Study of SYHA1807 in Subjects With Extensive-Stage Small Cell Lung Cancer | ||
NCT05027204 | A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN) | ||
NCT04689100 | Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor | ||
NCT05478785 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors | ||
NCT05720026 | Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer | ||
NCT05475717 | A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI | ||
NCT05354063 | A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults. | ||
NCT04645901 | A Study of SYHA1805 in Healthy Adult Subjects | ||
NCT04060290 | Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors | ||
NCT03776279 | A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma | ||
NCT03199261 | A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects | ||
NCT04325711 | A Study of CSPCHA131 in Patients With Advanced Solid Tumor | ||
NCT04859439 | A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment | ||
NCT05616494 | A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer | ||
NCT05125523 | A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors | ||
NCT02070523 | Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia: | ||
NCT05513664 | Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer | ||
NCT06688435 | A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis | ||
NCT04309968 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors | ||
NCT05055791 | A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies | ||
NCT06313086 | DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer | ||
NCT03239119 | The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus | ||
NCT06562894 | Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients | ||
NCT04197323 | Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran | ||
NCT03262948 | Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer | ||
NCT03994484 | Study of Dosage Exploration and Pharmacokinetics for HA121-28 Tablets | ||
NCT05097248 | Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy | ||
NCT04859426 | A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic Impairment | ||
NCT04161430 | A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients | ||
NCT07083505 | A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer | ||
NCT04900766 | A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma | ||
NCT02595242 | Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma | ||
NCT06957379 | Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy |